GLP-1 Agonism Extends Median Lifespan in Mice
A Nature Aging study finds that GLP-1 receptor agonism lengthens median lifespan in mice, adding pre-clinical longevity data to a drug class already reshaping metabolic medicine.
- GLP-1 receptor agonism extended median lifespan in treated mouse cohorts
- Study situates the effect within caloric-restriction-adjacent metabolic signalling pathways
- Pre-clinical lifespan extension observed in an already FDA-approved drug target class